571 results on '"Unger, Kristian"'
Search Results
2. Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data
3. ChatGPT's Gastrointestinal Tumor Board Tango: A limping dance partner?
4. Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
5. Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections
6. Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer
7. Mcl-1 deficiency in murine livers leads to nuclear polyploidisation and mitotic errors: Implications for hepatocellular carcinoma
8. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
9. HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
10. Sublethal necroptosis signaling promotes inflammation and liver cancer
11. DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
12. DeepClassPathway: Molecular pathway aware classification using explainable deep learning
13. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer
14. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
15. Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p
16. Surface-Based Deep Inspiration Breath-Hold Radiotherapy in Left-Sided Breast Cancer – Finalresults from the SAVE-HEART Study
17. Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis
18. Improved Outcome Prediction Across Data Sources Through Robust Parameter Tuning
19. p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model
20. NASH limits anti-tumour surveillance in immunotherapy-treated HCC
21. Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma
22. X-change symposium: status and future of modern radiation oncology—from technology to biology
23. Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts
24. Direct conversion of human fibroblasts into therapeutically active vascular wall-typical mesenchymal stem cells
25. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
26. Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
27. Molekulare Muster von strahlungsbedingtem Brustkrebs
28. Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
29. Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5
30. Data from Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach
31. Supplementary figure 2 from Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach
32. Supplementary figure 1 from Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach
33. Supplementary Fig. S1 from Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib
34. Supplementary Figure from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
35. Data from A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
36. Supplementary Tables from A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
37. Supplementary Figures from A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
38. Supplementary Data from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
39. Supplementary Table from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
40. Supplementary Methods from A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
41. Supplementary tables S1-3 and figure legends from Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib
42. A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment
43. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance
44. Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2
45. Single-center versus multi-center data sets for molecular prognostic modeling: a simulation study
46. Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
47. Prospektive Validierung einer prognostischen 4-miRNA-Signatur bei Glioblastom-Patienten: ARO-Studienpreis 2020
48. Lifetime study in mice after acute low-dose ionizing radiation: a multifactorial study with special focus on cataract risk
49. Differential Response and Priming Dose Effect on the Proteome of Human Fibroblast and Stem Cells Induced by Exposure to Low Doses of Ionizing Radiation
50. CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.